Found: 10
Select item for more details and to access through your institution.
Authors' Response to Huang et al.'s Comment on "Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance".
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Comment on "Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance".
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.
- Published in:
- Drug Safety, 2024, v. 47, n. 4, p. 355, doi. 10.1007/s40264-024-01400-0
- By:
- Publication type:
- Article
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy.
- Published in:
- Drug Safety, 2024, v. 47, n. 4, p. 321, doi. 10.1007/s40264-024-01399-4
- By:
- Publication type:
- Article
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study.
- Published in:
- Drug Safety, 2024, v. 47, n. 4, p. 377, doi. 10.1007/s40264-024-01397-6
- By:
- Publication type:
- Article
Exploring the Role of Guidelines in Contributing to Medication Errors: A Descriptive Analysis of National Patient Safety Incident Data.
- Published in:
- Drug Safety, 2024, v. 47, n. 4, p. 389, doi. 10.1007/s40264-024-01396-7
- By:
- Publication type:
- Article
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older
- Published in:
- Drug Safety, 2024, v. 47, n. 4, p. 365, doi. 10.1007/s40264-024-01395-8
- By:
- Publication type:
- Article
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative.
- Published in:
- Drug Safety, 2024, v. 47, n. 4, p. 301, doi. 10.1007/s40264-023-01390-5
- By:
- Publication type:
- Article
The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments.
- Published in:
- Drug Safety, 2024, v. 47, n. 4, p. 289, doi. 10.1007/s40264-023-01386-1
- By:
- Publication type:
- Article
Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis.
- Published in:
- Drug Safety, 2024, v. 47, n. 4, p. 333, doi. 10.1007/s40264-023-01383-4
- By:
- Publication type:
- Article